<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="436">
  <stage>Registered</stage>
  <submitdate>7/09/2005</submitdate>
  <approvaldate>13/09/2005</approvaldate>
  <actrnumber>ACTRN12605000378628</actrnumber>
  <trial_identification>
    <studytitle>Strength Training in Gestational Diabetes Mellitus (GDM)</studytitle>
    <scientifictitle>The efficacy and feasibility of progressive strength training in the management of glucose control in women with gestational diabetes</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Gestational Diabetes</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Diabetes</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Supervised strength training program (twice a week)-45min. The duration of the intervention depends on the duration of pregnancy and the time of recruitment. We are recruiting women any time between 24 and 32 weeks of gestation and they stay in the program up until the birth. So the intervention period varies for each woman.</interventions>
    <comparator>Usual care (control)</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Change in fasting</outcome>
      <timepoint>At one and a half hour post-prandial glucose between entry into the study and the week prior to delivery</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Changes in HbA1c</outcome>
      <timepoint>Between entry into the study and the week prior to delivery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Use of insulin, time until use of insulin, and insulin resistance.</outcome>
      <timepoint>Between entry into the study and the week prior to delivery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood pressure</outcome>
      <timepoint>Between entry into the study and the week prior to delivery.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Muscle strength</outcome>
      <timepoint>Between entry into the study and the week prior to delivery.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Diagnosed GDM (after an overnight fast, women undergo a 75mg OGTT, GDM is diagnosed if fasting plasma glucose &gt;/= 5.5, and/or 2hr plasma glucose &gt;/= 8.0mmol/l), 24-32 weeks of gestation, primagravida or multigravida.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Currently/recently (preceding 2 months) engaged in a regular exercise, significant medical or obstetric conditions (history of hypertension, pre-eclampsia, premature rapture of membranes, premature labour, PV bleeding or an incompetent cervix).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Sealed envelopes are held by an independent person, and opened by the independent person to assign the intervention group.</concealment>
    <sequence>Computer-generated random numbers (Excel), in blocks.</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/03/2005</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>70</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>International Diabetes Institute</primarysponsorname>
    <primarysponsoraddress>250 kooyong Rd, VIC, 3165</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>International Diabetes Institute</fundingname>
      <fundingaddress>250 kooyong Rd, VIC, 3165</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>None</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Research Ethics Committee at the Monash Medical Centre</ethicname>
      <ethicaddress />
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>A/Professor Jonathan Shaw</name>
      <address>International Diabetes Institute
250 Kooyong Rd
Caulfield Melbourne VIC 3162</address>
      <phone>+61 3 92585000</phone>
      <fax>+61 3 92585902</fax>
      <email>jshaw@idi.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Mrs Elena Vulikh</name>
      <address>International Diabetes Institute
250 Kooyong Rd
Caulfield Melbourne VIC 3162</address>
      <phone>+61 3 92585000</phone>
      <fax>+61 3 92585902</fax>
      <email>evulikh@idi.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>